Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Oral Oncol. 2016 Mar 19;56:32–39. doi: 10.1016/j.oraloncology.2016.02.015

Fig. 1.

Fig. 1

miR-107 and miR-138 are upregulated in SAHA treated HNSCC cell lines. Real time RT-PCR analysis of miR-107, miR-138 and RNU44 was performed with total RNA isolated from CAL27 and SCC25 cell lines treated with DMSO or SAHA (at different doses as indicated in Materials and methods) using validated TaqMan assays. Expression of miR-107/miR-138 was normalized with RNU44. Each assay was performed in triplicate and repeated twice. Data showing multifold increments in miR-107 (A and B), miR-138 (C and D), expressions in SAHA treated CAL 27 and SCC25 cell lines respectively. Data is presented as mean ± SD, *p-value (p ≤ 0.05).